Cell J. 2012;14(3):225-30. Epub 2012 Dec 12.
Expression of e-cadherin, leukemia inhibitory factor and progesterone receptor in mouse blastocysts after ovarian stimulation.
Cell journal
Bahar Movaghar, Saeedeh Askarian
Affiliations
Affiliations
- 1. Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
PMID: 23508459
PMCID: PMC3584431
Abstract
OBJECTIVE: The appropriate interaction between a blastocyst and the endometrium is essential for successful implantation. Numerous factors, including hormone receptors (progesterone receptor), cytokines [leukemia inhibitory factors (LIF)], and adherence molecules such as E-cadherin are involved in the cross-talk that occurs between the embryo and endometrium. Studies show that a lack of these genes impact endometrial receptivity. In this study, we compare the expression levels of E-cadherin, LIF, and progesterone receptor (PgR) genes in blastocysts that have been obtained from superovulated mice to those obtained from natural cycles.
MATERIALS AND METHODS: In this experimental study, for the experimental group, a total of 17 virgin female NMRI mice (6- 8 weeks old) were injected with 7.5 IU pregnant mare serum gonadotropin (PMSG). Their blastocysts (approximately n= 120) were flushed out after 3.5 days, following administration of human chorionic gonadotropin (hCG). The control group consisted of blastocysts from 62 female mice that were mated with male mice. The natural cycle blastocysts were flushed out from the female mice uteri 3.5 days after mating. The expression levels of E-cadherin, LIF, t PgR genes were examined by quantitative real-time reverse-transcriptase polymerase chain reaction (RT-PCR). Data were analyzed by the student's t-test (one sample t-test).
RESULTS: Expression levels of all studied genes were significantly lower in the hormone-treated group compared to the natural cycle blastocysts (p<0.05).
CONCLUSION: Although ovarian stimulation is utilized to obtain more oocytes in ART cycles, it seems that this could disadvantageous to implantation because of the decrease in expression levels of certain genes. Because of the important roles of E-cadherin, LIF, and progesterone receptor in the implantation process, we have shown lower expression levels of these genes in mouse blastocysts obtained from ovarian-stimulated mice than those derived from the natural cycle. The results observed in this study have shown the possibility of an unfavorable effect on implantation and pregnancy rate.
Keywords: Blastocyst; E-Cadherin; Leukemia Inhibitory Factor; Ovarian Stimulation; Progesterone Receptor
References
- Domest Anim Endocrinol. 2010 May;38(4):222-34 - PubMed
- Acta Obstet Gynecol Scand. 2002 Mar;81(3):195-203 - PubMed
- Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):855-9 - PubMed
- Fertil Steril. 2008 May;89(5 Suppl):1357-63 - PubMed
- Reprod Domest Anim. 2004 Feb;39(1):13-8 - PubMed
- Mech Dev. 1996 Jul;57(2):123-31 - PubMed
- Zhejiang Da Xue Xue Bao Yi Xue Ban. 2008 May;37(3):300-3 - PubMed
- Mol Hum Reprod. 1998 Nov;4(11):1039-44 - PubMed
- Hum Reprod. 1994 Dec;9(12):2405-10 - PubMed
- Fertil Steril. 2006 Feb;85(2):277-84 - PubMed
- Fertil Steril. 2011 Mar 15;95(4):1367-72 - PubMed
- Dev Biol. 2000 Jul 15;223(2):217-37 - PubMed
- Fertil Steril. 2010 May 15;93(8):2770-3 - PubMed
- Am J Physiol Endocrinol Metab. 2005 May;288(5):E845-51 - PubMed
- Hum Reprod. 2001 Mar;16(3):435-40 - PubMed
- Mol Biosyst. 2008 Aug;4(8):835-50 - PubMed
- Semin Reprod Med. 2009 Jan;27(1):90-102 - PubMed
- Endocrinology. 2007 Aug;148(8):3922-31 - PubMed
- Reprod Biol. 2008 Nov;8(3):179-211 - PubMed
- Hum Reprod. 2001 Feb;16(2):221-5 - PubMed
- Hum Reprod. 2004 Jun;19(6):1457-60 - PubMed
- Acta Obstet Gynecol Scand. 2008;87(7):775-82 - PubMed
- Fertil Steril. 2003 May;79(5):1187-93 - PubMed
- Hum Reprod. 2008 Mar;23(3):499-503 - PubMed
- Reprod Biomed Online. 2003 Jul-Aug;7(1):105-9 - PubMed
- Mol Endocrinol. 2000 Aug;14(8):1147-61 - PubMed
- Fertil Steril. 1999 Jun;71(6):1040-7 - PubMed
- Exp Anim. 2008 Jan;57(1):27-34 - PubMed
Publication Types